Cargando…

Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database

(1) Background: Oxaliplatin is used as first-line chemotherapy not only for colorectal cancer but also for gastric and pancreatic cancers. However, it induces peripheral neuropathy with high frequency as an adverse event, and there is no effective preventive or therapeutic method. (2) Methods: The e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mine, Keisuke, Kawashiri, Takehiro, Inoue, Mizuki, Kobayashi, Daisuke, Mori, Kohei, Hiromoto, Shiori, Kudamatsu, Hibiki, Uchida, Mayako, Egashira, Nobuaki, Koyanagi, Satoru, Ohdo, Shigehiro, Shimazoe, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408309/ https://www.ncbi.nlm.nih.gov/pubmed/36012136 http://dx.doi.org/10.3390/ijms23168859

Ejemplares similares

Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mori, Kohei, et al.
Publicado: (2022)

Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
por: Shigematsu, Nao, et al.
Publicado: (2020)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Hiromoto, Shiori, et al.
Publicado: (2021)

Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents
por: Kawashiri, Takehiro, et al.
Publicado: (2020)

Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Fujita, Shunsuke, et al.
Publicado: (2015)

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
por: Egashira, Nobuaki
Publicado: (2021)

Diurnal expression of MRP4 in bone marrow cells underlies the dosing-time dependent changes in the oxaliplatin-induced myelotoxicity
por: Kato, Mizuki, et al.
Publicado: (2020)

Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats
por: Mihara, Yuki, et al.
Publicado: (2011)

Inhibition of Ca(2+)/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
por: Shirahama, Masafumi, et al.
Publicado: (2012)

L type Ca(2+ )channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats
por: Kawashiri, Takehiro, et al.
Publicado: (2012)

Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug
por: Yamamoto, Shota, et al.
Publicado: (2017)

RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene
por: Omata, Yuji, et al.
Publicado: (2021)

Dysfunction of the circadian transcriptional factor CLOCK in mice resists chemical carcinogen-induced tumorigenesis
por: Hashikawa, Ken-ichi, et al.
Publicado: (2017)

RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells
por: Omata, Yuji, et al.
Publicado: (2022)

Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice
por: Tsuruta, Akito, et al.
Publicado: (2022)

Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
por: Yamamoto, Shota, et al.
Publicado: (2021)

Circadian clock component PERIOD2 regulates diurnal expression of Na(+)/H(+) exchanger regulatory factor-1 and its scaffolding function
por: Tsurudome, Yuya, et al.
Publicado: (2018)

Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain
por: Kusunose, Naoki, et al.
Publicado: (2010)

Management of oxaliplatin-induced peripheral neuropathy
por: Saif, M Wasif, et al.
Publicado: (2005)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
por: Yamamoto, Shota, et al.
Publicado: (2021)

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
por: Yoshida, Naohisa, et al.
Publicado: (2013)

Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells
por: Ogino, Takashi, et al.
Publicado: (2021)

Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2020)

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
por: Iida, Hiroshi, et al.
Publicado: (2012)

Omeprazole-associated rhabdomyolysis
por: Tanaka, Kumiko, et al.
Publicado: (2014)

¿Omeprazol para todos?
por: Sánchez, Diego P., et al.
Publicado: (2014)

Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
por: Yoshida, Yoichiro, et al.
Publicado: (2015)

Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2017)

Differences in recognition of similar medication names between pharmacists and nurses: a retrospective study
por: Tsuji, Toshikazu, et al.
Publicado: (2015)

A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2018)

The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S
por: Hayashi, Yoshinori, et al.
Publicado: (2013)

Drug interaction: Omeprazole and Phenprocoumon
por: Enderle, Christa, et al.
Publicado: (2001)

Induction of Erythrocyte Shrinkage by Omeprazole
por: Naveed, Ayesha, et al.
Publicado: (2020)

Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Choi, Seunghwan, et al.
Publicado: (2019)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
por: Giampieri, Riccardo, et al.
Publicado: (2019)

Metformin protects from oxaliplatin induced peripheral neuropathy in rats
por: Martinez, N.W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5rk52ncioev56c8b2t5ks9ju68